OHSU and the Department of Energy’s Pacific Northwest National Laboratory in Richland, Wash., have formed the OHSU-PNNL Northwest Co-Laboratory for Integrated ‘Omics. This partnership allows both parties to share their research programs and leading-edge technology for biological mass spectrometry to pursue disease markers for new therapies. In essence, the two entities are working together to answer some of the world’s most complex biomedical questions and accelerate discovery.
Through a memorandum of understanding, the institutions have formed the co-laboratory to expand existing individual collaborations and provide enhanced access to state-of-the-art mass spectrometry instrumentation and technical expertise. One benefit? A streamlined workflow, which is critical as the dual lab sets to work on several experiments related to developmental origins of health and disease, as well as stroke, later this year. This new initiative builds on the strong partnership of OHSU and PNNL and builds on work from the School of Medicine and the OHSU Proteomics Shared Resource.
Read the news release in its entirety here.
The Vollum Writing Class is a 6-week professional science writing course open to OHSU graduate students, postdoctoral fellows, and faculty.
This class uses short lectures, class discussion, and workshop-style writing assignments to help researchers learn to write better papers and grants. Topics include:
- The basic elements of good scientific writing style, including sentence and document structure
- Insight into scientific conventions regarding grammar, punctuation, and usage;
- Strategies for revising
- Dealing with writer’s block and time management
- Best practices for writing introductions, results, discussions, and grant proposals
The class runs for six weeks, 9:30 a.m. to 12 p.m. on Wednesdays, beginning July 1, 2015. Six individual tutorials with the instructor are included. There are no prerequisites for this non-credit professional development course, but you should not take the class unless you have enough data to write about.
The course carries a fee of $500 per student (unless you are in a Vollum lab or part of certain graduate Ph.D. programs). Questions? Contact firstname.lastname@example.org.
Access Compass to register for the Vollum Writing Class.
The Knight Cardiovascular Institute invites you to attend “OregonHeart: Developing a total artificial heart,” a lecture providing an overview of the KCVI’s new company aimed at developing a successful total artificial heart device to treat patients with end-stage heart failure. OregonHeart’s Chief Scientific Officer and renowned inventor of the Hemopump, Richard Wampler, will present, along with other company representatives and OHSU faculty collaborators.
Thursday, May 28, 2015
5 to 6:30 p.m.
Collaborative Life Sciences Building, room 2S060
Light reception to follow.
OHSU’s MedTech Alliance program was founded by OHSU Technology Transfer & Business Development and the Oregon Clinical & Translational Research Institute. This program connects OHSU inventors with potential investors and industry collaborators. OHSU has many innovative medical technology inventions in the device and diagnostic space. Some of these inventions would benefit from additional resources and support before they can be commercialized. The goal of the MedTech Alliance is to facilitate collaborations and advance OHSU technologies.
Join the techs and inventors at the spring 2015 MedTech Alliance meeting.
MedTech Alliance meeting
5 to 7:30 p.m.
Collaborative Life Sciences Building, room 3A001
The techs and inventors participating include:
- Antithrombotic drugs without bleeding side effects: Andras Gruber, M.D/, School of Medicine
- Bioabsorbable dural clips: Neil Roundy, M.D. and Rachel Dreilinger, School of Medicine
- Accurate in-home collection of blood samples: Andrew Chitty, M.B.A. and Dorota Shortell, M.S.M.E., School of Medicine
- New generation of dental composites: Carmem Pfeifer, D.D.S., Ph.D., School of Dentistry
Learn more about MedTech and how faculty can participate.
What new research is under way at OHSU? What will be the next big thing to come out of an OHSU lab? We asked all faculty members hired since January 2013 to join us at Research Week to share their exciting new work with the rest of the research community. New to Research Week in 2015, this event allows faculty members new to the university to showcase their project or program in a five-minute, one-slide presentation.
Today! New Faculty Lightning Rounds
3:30 to 5 p.m.
Old Library Auditorium
Find out what the following researchers are up to in their labs:
- Sergio Fazio, M.D., Ph.D.
The William and Sonja Connor Chair of Preventive Cardiology
Professor of Medicine and Physiology and Pharmacology
Director, Center for Preventive Cardiology, Knight Cardiovascular Institute
- Maros Ferencik, M.D., Ph.D.
Assistant professor of Medicine
Director of Cardiovascular CT Research
Director of Cardio-Oncology Program, Knight Cardiovascular Institute
- Pam Cassidy, Ph.D.
Research associate professor, Department of Dermatology
- Hagai Tavori, Ph.D.
Research instructor, Knight Cardiovascular Institute
- Larisa Tereshchenko, M.D., Ph.D.
Assistant professor, Knight Cardiovascular Institute
- Matt Whorton, Ph.D.
Assistant scientist, Vollum Institute
- Raymond Bergan, M.D.
Head, Division of Hematology/Oncology
Associate director, Knight Cancer Institute
- Matthew Drake, M.D.
Assistant professor, Division of Pulmonary and Critical Care Medicine
- Shawn Chavez, Ph.D.
Assistant Scientist, Division of Reproductive & Developmental Sciences
Oregon National Primate Research Center
- Sivaraman Prakasam, B.D.S., M.S.D., Ph.D.
Diplomate, American Board of Periodontology
Assistant professor, Department of Periodontology, School of Dentistry
- Mitchell Sally, M.D.
Assistant professor of Surgery, Division of Trauma, Critical Care, and Acute Care Surgery
GME Site Director, Surgical ICU Rotation, VA Portland Health Care System
- Patricia Berry, Ph.D., R.N., ACHPN, FPCN, FAAN
Professor, director, Hartford Center of Gerontological Nursing Excellence at OHSU
- Dmitry Dukhovny, M.D., Ph.D.
Assistant professor of Pediatrics, Department of Pediatrics, Division of Neonatology
- Marina Guizzetti, Ph.D.
Associate professor, research biologist, Department of Behavioral Neuroscience
VA Portland Health Care System
- Khaled Tolba, M.D.
Assistant professor of Medical Oncology
Leader, Thoracic Oncology and Head and Neck Cancer, Knight Cancer Institute
- Alexey Danilov, M.D., Ph.D.
Assistant professor, Knight Cancer Institute
- Rhonda MacAllister, D.V.M.
Assistant veterinarian, Oregon National Primate Research Center
- Sudarshan Anand, Ph.D.
Assistant professor, Cell, Developmental and Cancer Biology, Knight Cancer Institute
- Adam Margolin, Ph.D.
Director, Computational Biology
eIRB Upgrade: Modifications & Continuing Review Questionnaires
Presented by IRB Manager Dave Holmgren
Wednesday, May 20
10 to 11:30 a.m.
OHSU Hospital, 8th floor auditorium
Are you involved with Human Subjects research? Come to the eIRB Upgrade Demo! This brown bag we will be giving an overall demonstration of the new eIRB system. You can see a presentation of the new Initial Submissions process, the modifications and CRQs and the new Reportable New Information (RNI) system. This brown bag session will be open for questions and answers.
May Design Studio has been canceled.
Are you submitting a Career Development K award? Or your first R01? A similar major grant?
The Oregon Clinical and Translational Research Institute has an opportunity for basic and clinical scientists to present their research and get constructive feedback from OHSU scientists to improve their chances of success. The OCTRI Design Studio has helped many OHSU researchers improve their aims and identify important areas of improvement before submitting awards.
The Design Studio has openings at two scheduled meetings for this spring:
- Tuesday, May 12, 12 to 2 p.m., Kohler Pavilion 13000A
- Tuesday, June 9, 12 to 2 p.m., Kohler Pavilion 13000A
OCTRI’s Design Studio has been a great opportunity for basic scientists as well as clinical scientists at all levels of training. Learn more about Design Studio, or contact Karen McCracken about presenting.
Research Week is going mobile for 2015! Don’t miss any of the events you want to attend this year with the new Research Week Guidebook app. The app allows you to view the conference agenda, read abstracts, search for presenters, and add events to your personal calendar. All you have to do is download Guidebook from the App Store or Google Play on your phone or other device and search for Research Week 2015. No purchase or login necessary.
Mobile tracking not your thing? You can always find the Research Week agenda online here, or pick up a program when you come to Monday’s opening events.
You are invited to watch seasoned reviewers discuss NIH proposals as if you were there! The Mock NIH Study Section, led by Charles Rafferty, Ph.D., will review NIH K career development and R01 applications with a panel of OHSU faculty acting as reviewers. This event will demonstrate how grants are evaluated and discussed through the NIH peer review process – and provide insight into improving your own grantsmanship. In addition, we need your participation! The audience will be asked to score the applications with results displaying in real time.
Mock Study Section
Thursday, May 7
12 to 1:30 p.m.
Old Library Auditorium
In preparation for the event, please read the two grant applications – the K23 and the R01 – and browse through the NIH review materials, including critique templates, review guidance and NIH scoring table. If you’re short on time, read the R01′s Specific Aims and the K23′s Career Development Plan. As you will see, these are actual NIH proposals that have been redacted to protect the innocent.
All materials can be found here. You need your OHSU credentials to log in.
Charles N. Rafferty, Ph.D., is a health research and grants policy consultant with extensive experience in managing research programs and planning and conducting peer review in environmental, and occupational health and clinical research in musculoskeletal, skin, and rheumatic diseases. He recently retired from his position as Chief of the Scientific Review Branch at the National Institute of Arthritis, Musculoskeletal, and Skin Diseases (NIAMS) at the National Institutes of Health (NIH). In this position, he oversaw all grant and contract peer review activities carried out by NIAMS.
The Mock Study Section is sponsored by Oregon Clinical & Translational Research Institute.
Business Oregon and the Oregon Clinical and Translational Research Institute’s Biomedical Innovation Program are continuing their pilot program to help Oregon small businesses access federal funding through successful Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) grant applications. Currently, only OHSU startups or companies with OHSU intellectual property are eligible to apply.
- Due date: July 6, 2015 for the SBIR/STTR Sept. 5, 2015 deadline (Phase 0 submissions must be received a minimum of nine weeks prior to SBIR/STTR due date)
- In addition to the services provided by reviewers, Phase 0 program applicants can request up to $3,725 for SBIR/STTR grant application preparation services.
Please see the complete request for applications for allowable expenses here.
The specific goal of the Phase 0 program is to improve the competitiveness of SBIR/STTR applications and lead to award funding. The Phase 0 program provides expert reviews of draft SBIR/STTR grant proposals, as well as support for proposal development. Grant review benefits include:
• Strategic advice from experienced translational scientists
• Writing guidance and feedback on grant structure, based on NIH review criteria
• Identification of potential scientific consultants or advisers
• Recommendations for additional preliminary studies or data analysis
• Application weaknesses highlighted prior to submission
The program thus far has supported four Oregon companies submitting SBIR or STTR applications. Becky Voorheis, CEO of Quickbeam and an SBIR Phase 0 awardee, said about the program: “I can’t overstate how valuable the Phase 0 grant was to us in the grant preparation. We received extremely high quality feedback and support from our reviewers.”
Please direct program inquiries to:
Jonathan Jubera, OHSU Biomedical Innovation Program
Mark Brady, Business Oregon